Enabling Access to the 4th Largest Pharmaceutical Market in the World and its 210 Million ConsumersHICKSVILLE, NY / ACCESSWIRE / March 3, 2022 / Can B Corp. (OTCQB:CANBD) (“Can B” or the “Company”), a health and wellness company specializing in …
Enabling Access to the 4th Largest Pharmaceutical Market in the World and its 210 Million Consumers
HICKSVILLE, NY / ACCESSWIRE / March 3, 2022 / Can B Corp. (OTCQB:CANBD) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, is pleased to announce its formation of a joint venture with PrimeX, a marketing, sales, and distribution company, for its cbd gummies products in Brazil.
PrimeX has a contract with Biocase Brasil to produce cbd gummies products for the Brazilian market.
Biocase is a company focused on: local distribution, an intensive education program for doctors (MDs), production of oils, capsules, and creams through local facilities, and the development of a biotech laboratory for cannabis testing and extraction.
